RT Journal Article
SR Electronic
T1 Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry” by Sparks <em>et al</em>
JF Annals of the Rheumatic Diseases
JO Ann Rheum Dis
FD BMJ Publishing Group Ltd and European League Against Rheumatism
SP annrheumdis-2021-220932
DO 10.1136/annrheumdis-2021-220932
A1 Elisa Gremese
A1 Gianfranco Ferraccioli
YR 2021
UL http://ard.bmj.com/content/early/2021/08/22/annrheumdis-2021-220932.abstract
AB